The following resolutions were passed at the Annual General Meeting (the "AGM") of
Adoption of Income Statement and Balance Sheet for the Financial Year 2022 and Discharge from Liability
The AGM resolved to adopt the income statement and the consolidated income statement for the financial year 2022 as well as the balance sheet and the consolidated balance sheet as of
Allocation of Profits
The AGM resolved, in accordance with the Board of Directors' proposal, that no dividend be paid for 2022 and that the profits available to the AGM shall be carried forward.
Election of Board Members, Auditors, Fees to the Board of Directors and Auditors
The AGM resolved, in accordance with the Nomination Committee's proposal, that the number of members of the Board of Directors shall be four without deputies and that the number of auditors shall be one registered accounting firm.
In accordance with the Nomination Committee's proposal,
The AGM resolved, in accordance with the Nomination Committee's proposal, that fees to members of the Board shall be paid with
Principles for the appointment of the members of the Nomination Committee
The AGM resolved, in accordance with the Nomination Committee's proposal, to amend the principles for the appointment of the members of the Nomination Committee so that the Nomination Committee shall consist of three members appointed by the largest shareholders. No other changes have been made regarding the principles.
Authorisation for the Board of Directors to resolve on new share issues, etc.
The AGM resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to, for the period until the end of the next Annual General Meeting, on one or several occasions and with or without deviation from the shareholder's preferential rights, resolve on new issues of shares, warrants and/or convertibles entitling to shares equal to no more than 20 per cent of the, at the time of the issue resolution, registered share capital of the Company. The authorization may also be exercised for issues of shares, warrants and/or convertibles with preferential rights for shareholders corresponding to the available capacity according to the Company's Articles of Association at the time of the issue resolution.
Deviation from the shareholders' preferential rights shall be possible in connection with future investments in the form of acquisitions of operations, companies, shares in companies or otherwise for the Company's future expansion. If the Board resolves on an issue with deviation from the shareholders' preferential rights, the rationale shall be that the Board shall be able to issue shares in the Company to be used as a means of in-kind payment or the right to offset debt, or to in a flexible and cost-efficient manner raise capital to use as means of payment or to continuously adjust the Company's capital structure.
For more information, please contact:
Phone: +46 725 502 306
E-mail: david.larsson@sileon.com
The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CEST on
About
https://news.cision.com/sileon-ab/r/bulletin-from-annual-general-meeting-in-sileon-ab--publ-,c3762074
https://mb.cision.com/Main/15210/3762074/2026658.pdf
(c) 2023 Cision. All rights reserved., source